Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Darwin's Ark is a non-profit citizen science organization that leverages large-scale genomic data to study canine health, behavior, and evolution. By collecting DNA samples and owner-reported data from thousands of pet dogs, the organization identifies genetic variants associated with complex traits and diseases, including cancer and aging. The project operates as a collaborative effort between the Broad Institute and UMass Chan Medical School, aiming to bridge the gap between veterinary and human medicine through comparative genomics. Their open-data approach allows researchers worldwide to access high-quality datasets to accelerate discoveries in precision medicine. Through community engagement, Darwin's Ark empowers pet owners to contribute directly to scientific breakthroughs that benefit both dogs and humans.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darwin's Ark.